‘s () Alexis Abraham talks to Proactive London’s Katie Pilbeam about their first day of trading on the London Stock Exchange.
Abraham says he is ‘delighted the UK has embraced cannabinoids and our listing with such enthusiasm’.
The provider of premium consumer products based on biosynthetic cannabinoids, which are compounds produced in the lab from cannabis plants, completed its initial public offering (IPO) after a £13mln fundraising.
Read More: Cellular Goods ‘delighted UK has embraced cannabinoids and listing’ as company